LA JOLLA PHARMACEUT (NASDAQ:LJPC)
0.07
-0 (-0%)
| LA JOLLA PHARMACEUT (NASDAQ:LJPC) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.07 | 52 Week High | $3.20 | ||
| Open | $0.07 | 52 Week Low | $0.04 | ||
| Day High | $0.07 | P/E | N/A | ||
| Day Low | $0.06 | EPS | $-0.72 | ||
| Volume | 1,509,747 | ||||
| More LJPC Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| BMRN | 5 | PERY | 2 |
| IXYS | 2 | PGN | 2 |
| AA | 2 | LNDC | 2 |
| SMSC | 2 | FFIV | 2 |
| LVB | 2 | XXIA | 2 |
| GPN | 2 | NTCT | 2 |
Entities who have mentioned LJPC
- Dividend | View Related Stories »
- After-Hours Movers | View Related Stories »
- Piper Jaffray | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Benchmark Capital | View Related Stories »
- Goldman Sachs | View Related Stories »
- Wachovia | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
StreetInsider.com Major News for LJPC
View All ReportsStreetInsider.com Reports on LJPC
- La Jolla Pharmaceutical (LJPC) Announces the Adjournment of Special Meeting of Stockholders
- La Jolla Pharmaceutical (LJPC) Adjourns Special Meeting of Shareholders
- LJPC, CIT, SPWRA, CNW, BDK, LDK, See Volume and Upside Price Action
- La Jolla Pharmaceutical (LJPC) to Cut Workforce
- Unusual 11 Mid-Day Movers 2/12: DISK, DFT, BWLD, ATRO Higher; LJPC, PACR, TEX, BSQR Lower
View All Press ReleasesCompany Press Releases on LJPC
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
- La Jolla Pharmaceutical Company to Seek Stockholder Approval of Dissolution
StreetInsider Reports on LJPC by Category
View All BlogsBlogs on LJPC
- La Jolla Is Too Much of a Gamble Right Now
- Biotech Discounts Galore
- Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
- Where Might Genentech Investors Redeploy $47B?
- Chink in the Biotechnology Armor
Comments on recent LJPC articles
Comments on LJPC
No comments are currently available.
on Sep 24, 2009
at 11:31 PM STOCK VALUE IS THIS A GOOD BUY? I AM THINKING THAT THIS SHOULD GO UP IN VALUE, CAN SOMEONE REPLY WITH A THOUGHT
Article: La Jolla Pharmaceutical (LJPC) to Cut Workforce